Critical Biologics' Series A - II Round

Critical Biologics raised a round of funding on August 11, 2008. Investors include Morningside Group (晨兴集团).

Critical Biologics Corporation (CBC), based in Cambridge, MA, is a small biotechnology company committed to making available products to address the many unmet medical needs in Critical Care Medicine.…

Articles about Critical Biologics' Series A - II Round: